[Other] Real-world Outcomes and Tolerability of Nintedanib in Patients With Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease: A Retrospective Study From a Single Center in a Middle Eastern

thuycan Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-08 10:59
Reward10points

Namas, R., Al Qassimi, S., Elarabi, M., Khan, S., Almarzooqi, A., Mubashir, A., Hafiz, W., & Chapman, J. (2026). Real-world Outcomes and Tolerability of Nintedanib in Patients With Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease: A Retrospective Study From a Single Center in a Middle Eastern Population. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 32(1), 8–13. https://doi.org/10.1097/RHU.0000000000002281
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list